These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20627384)

  • 21. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
    Zhang F; Hao Y; Pang W
    Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Array comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities.
    Vercauteren SM; Sung S; Starczynowski DT; Lam WL; Bruyere H; Horsman DE; Tsang P; Leitch H; Karsan A
    Am J Clin Pathol; 2010 Jul; 134(1):119-26. PubMed ID: 20551276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chromosomal aberrations in myelodysplastic syndrome].
    Ol'shanskaia IuV; Domracheva EV; Udovichenko AI; Vodinskaia LA; Zakharova AV; Parovichnikova EN; Tsvetaeva NV; Mikhaĭlova EA; Glasko EN; Kolosova LIu; Kokhno AN; Tikhonova LIu; Shitareva TV; Smirnova EA; Alimova GA; Shirin AD; Vinogradova OIu; Khoroshko ND; Savchenko VG
    Ter Arkh; 2005; 77(7):27-33. PubMed ID: 16116905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome.
    Bogdanović G; Jurisić V; Kraguljac N; Mrdjanović J; Jakimov D; Krtolica K; Krajnović M; Magić Z; Stojiljković B; Andrijević L; Srdić T; Baltić M; Popović S
    Leuk Res; 2007 Aug; 31(8):1097-1105. PubMed ID: 17350682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.
    Lopez-Villar O; Garcia JL; Sanchez-Guijo FM; Robledo C; Villaron EM; Hernández-Campo P; Lopez-Holgado N; Diez-Campelo M; Barbado MV; Perez-Simon JA; Hernández-Rivas JM; San-Miguel JF; del Cañizo MC
    Leukemia; 2009 Apr; 23(4):664-72. PubMed ID: 19151777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Czechoslovak MDS Cooperative Group.
    Michalova K; Musilova J; Zemanova Z
    Ann Genet; 1991; 34(3-4):212-8. PubMed ID: 1809229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.
    Santana-Davila R; Holtan SG; Dewald GW; Ketterling RP; Knudson RA; Hanson CA; Steensma DP; Tefferi A
    Leuk Res; 2008 Mar; 32(3):407-11. PubMed ID: 17707907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report.
    Znoyko I; Stuart RK; Ellingham T; Winters J; Wolff DJ; Quigley DI
    Cancer Genet Cytogenet; 2008 May; 183(1):64-8. PubMed ID: 18474300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
    Cilloni D; Gottardi E; Messa F; Fava M; Scaravaglio P; Bertini M; Girotto M; Marinone C; Ferrero D; Gallamini A; Levis A; Saglio G;
    J Clin Oncol; 2003 May; 21(10):1988-95. PubMed ID: 12743153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
    Pellagatti A; Cazzola M; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Verma A; Norbury CJ; Hellström-Lindberg E; Wainscoat JS; Boultwood J
    Leukemia; 2010 Apr; 24(4):756-64. PubMed ID: 20220779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes.
    Olney HJ; Le Beau MM
    Leuk Res; 2007 Apr; 31(4):427-34. PubMed ID: 17161457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS).
    Economopoulou C; Pappa V; Papageorgiou S; Kontsioti F; Economopoulou P; Charitidou E; Girkas K; Kapsimali V; Papasteriadi C; Tsirigotis P; Papageorgiou E; Dervenoulas J; Economopoulos T
    Ann Hematol; 2010 Apr; 89(4):349-58. PubMed ID: 19813013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deregulation of microRNAs in myelodysplastic syndrome.
    Rhyasen GW; Starczynowski DT
    Leukemia; 2012 Jan; 26(1):13-22. PubMed ID: 21852786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment in immuno-modulatory function of Flk1(+)CD31(-)CD34(-) MSCs from MDS-RA patients.
    Han Q; Sun Z; Liu L; Chen B; Cao Y; Li K; Zhao RC
    Leuk Res; 2007 Nov; 31(11):1469-78. PubMed ID: 17360037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow morphology in myelodysplastic syndrome associated with isolated del(5q).
    Naresh KN; Reid A
    Am J Hematol; 2010 Aug; 85(8):609-10. PubMed ID: 20658591
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence for expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasia.
    Xu D; Schultz C; Akker Y; Cannizzaro L; Ramesh KH; Du J; Ratech H
    Am J Hematol; 2003 Sep; 74(1):9-16. PubMed ID: 12949884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical significance of continuous karyotyping in myelodysplastic syndromes].
    Lai YY; Qiu JY; Zhang Y; Zhang Y; Shi Y; He Q; Dang H; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):645-8. PubMed ID: 15634565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes.
    Choi JS; Nam MH; Yoon SY; Kang SH
    Leuk Res; 2015 Jul; 39(7):763-8. PubMed ID: 25975751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression.
    Jang SJ; Choi IS; Park G; Moon DS; Choi JS; Nam MH; Yoon SY; Choi CH; Kang SH
    Leuk Res; 2016 Aug; 47():172-7. PubMed ID: 27379838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.
    Oliva EN; Cuzzola M; Aloe Spiriti MA; Poloni A; Laganà C; Rigolino C; Morabito F; Galimberti S; Ghio R; Cortelezzi A; Palumbo GA; Sanpaolo G; Finelli C; Ricco A; Volpe A; Rodà F; Breccia M; Alimena G; Nobile F; Latagliata R
    Ann Hematol; 2013 Jan; 92(1):25-32. PubMed ID: 22983750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.